{"title":"Neutrophil Adhesion and Migration: Another Role of the Glucose-6-Phosphate Transporter","authors":"H. Jun, J. Chou","doi":"10.4172/2168-958X.1000124","DOIUrl":null,"url":null,"abstract":"Glycogen storage disease type Ib (GSD-Ib) is caused by a deficiency in a glucose-6-phosphate transporter (G6PT) that belongs to the solute-carrier-37 family of endoplasmic reticulum (ER)-associated sugar-phosphate/phosphate exchangers [1,2]. The primary in vivo function of the ubiquitously expressed G6PT protein is to translocate G6P from the cytoplasm into the ER lumen where it couples with either the liver/kidney/intestine-restricted glucose-6-phosphatase-α (G6Pase-α) or the ubiquitously expressed G6Pase-ß to hydrolyze G6P to glucose and phosphate [3,4]. The G6PT/G6Pase-α complex maintains interprandial glucose homeostasis and the G6PT/G6Pase-ß complex maintains neutrophil energy homeostasis and functionality. Therefore, GSD-Ib is an autosomal recessive metabolic and immune disorder characterized by impaired glucose homeostasis, neutropenia and neutrophil dysfunction [3,4]. Recently, we showed that G6PTdeficient neutrophils from GSD-Ib patients receiving granulocytecolony stimulating factor (G-CSF) therapy exhibited impaired energy homeostasis and function [5], suggesting that G6PT-regulated G6P metabolism is important for neutrophil function. However, G-CSF failed to correct impaired neutrophil energy homeostasis in GSD-Ib [5].","PeriodicalId":92404,"journal":{"name":"Journal of glycobiology","volume":"6 1","pages":"1-2"},"PeriodicalIF":0.0000,"publicationDate":"2017-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of glycobiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2168-958X.1000124","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Glycogen storage disease type Ib (GSD-Ib) is caused by a deficiency in a glucose-6-phosphate transporter (G6PT) that belongs to the solute-carrier-37 family of endoplasmic reticulum (ER)-associated sugar-phosphate/phosphate exchangers [1,2]. The primary in vivo function of the ubiquitously expressed G6PT protein is to translocate G6P from the cytoplasm into the ER lumen where it couples with either the liver/kidney/intestine-restricted glucose-6-phosphatase-α (G6Pase-α) or the ubiquitously expressed G6Pase-ß to hydrolyze G6P to glucose and phosphate [3,4]. The G6PT/G6Pase-α complex maintains interprandial glucose homeostasis and the G6PT/G6Pase-ß complex maintains neutrophil energy homeostasis and functionality. Therefore, GSD-Ib is an autosomal recessive metabolic and immune disorder characterized by impaired glucose homeostasis, neutropenia and neutrophil dysfunction [3,4]. Recently, we showed that G6PTdeficient neutrophils from GSD-Ib patients receiving granulocytecolony stimulating factor (G-CSF) therapy exhibited impaired energy homeostasis and function [5], suggesting that G6PT-regulated G6P metabolism is important for neutrophil function. However, G-CSF failed to correct impaired neutrophil energy homeostasis in GSD-Ib [5].